Kenneth Krogulski - 16 Aug 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
16 Aug 2023
Transactions value $
$6,420
Form type
4
Filing time
08 Sep 2023, 18:04:50 UTC
Previous filing
27 Mar 2023
Next filing
19 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $543 +325 +0.15% $1.67 210,280 16 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $562 +325 +0.15% $1.73 210,605 17 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $562 +325 +0.15% $1.73 210,930 18 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $556 +325 +0.15% $1.71 211,255 21 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $569 +325 +0.15% $1.75 211,580 22 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $562 +325 +0.15% $1.73 211,905 23 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $226 +134 +0.06% $1.69 212,039 24 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $562 +325 +0.15% $1.73 212,364 25 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $566 +325 +0.15% $1.74 212,689 28 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $604 +355 +0.17% $1.70 213,044 29 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $556 +325 +0.15% $1.71 213,369 30 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $552 +325 +0.15% $1.70 213,694 31 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023.